top of page

SciFiMed will help patients suffering from

 

impaired defence against infections,

incurable renal,

autoimmune or 

eye diseases.

 

All these diseases share an association with dysregulation of the complement system, which is a major component of the immune system.

Complement factor H (FH) and FH-related (FHR) proteins are components of the complement system that are strongly associated with systemic and organ-specific complement-mediated pathologies. In contrast to FH, the function of the remaining six highly homologous FHR proteins is mostly unknown and, hence, their role in the different disease-specific pathogenic mechanisms remain elusive.

Spirit_scifimed.png

Our EU consortium successfully unraveled the mysteries of the FH-protein family's contributions to diseases.

Through an ambitious and transdisciplinary fundamental science-to-technology transfer, we developed specific antibodies and ELISA assays, which are now commercially available. 

Additionally, we established a proof-of-principle for a novel multiplex detection assay and innovative functional analysis systems, both of which provide the basis for future developments.

This high-impact project advanced immunological research across Europe, promoted new product developments by bioanalytical companies, modernized the EU diagnostic market, and opened new perspectives for patient treatment, ultimately paving the way for novel therapeutic strategies.

Man jump through the gap between hill..j
"Everything is possible,
even the impossible"

Mary Poppins

flag_yellow_high.jpg

This project has received funding from the European Union’s Horizon 2020

research and innovation programme under grant agreement No 899163

  • LinkedIn

©2020 by SciFiMed.

bottom of page